These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9109433)

  • 1. Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.
    Kretz-Rommel A; Duncan SR; Rubin RL
    J Clin Invest; 1997 Apr; 99(8):1888-96. PubMed ID: 9109433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1999 Jan; 162(2):813-20. PubMed ID: 9916703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nondeletional mechanism for central T-cell tolerance.
    Rubin RL; Kretz-Rommel A
    Crit Rev Immunol; 2001; 21(1-3):29-40. PubMed ID: 11642611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
    Mongey AB; Hess E
    J Rheumatol; 2001 Sep; 28(9):1992-8. PubMed ID: 11550965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus.
    Rubin RL; Kretz-Rommel A
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):803-6. PubMed ID: 10502546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.
    Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD
    J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
    Portanova JP; Claman HN; Kotzin BL
    J Immunol; 1985 Dec; 135(6):3850-6. PubMed ID: 3877758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of positive selection of thymocytes causes autoimmunity.
    Kretz-Rommel A; Rubin RL
    Nat Med; 2000 Mar; 6(3):298-305. PubMed ID: 10700232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolite of the lupus-inducing drug procainamide prevents anergy induction in T cell clones.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1997 May; 158(9):4465-70. PubMed ID: 9127012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.
    Clark AG; Fan Q; Brady GF; Mackin KM; Coffman ED; Weston ML; Foster MH
    Autoimmunity; 2013 May; 46(3):188-204. PubMed ID: 23157336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cellular events in systemic autoimmunity driven by chromatin-reactive T cells.
    Kretz-Rommel A; Rubin RL
    Cell Immunol; 2001 Mar; 208(2):125-36. PubMed ID: 11333145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J; Mamula MJ
    Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin.
    Portanova JP; Arndt RE; Kotzin BL
    J Immunol; 1988 Feb; 140(3):755-60. PubMed ID: 3339241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.
    Quddus J; Johnson KJ; Gavalchin J; Amento EP; Chrisp CE; Yung RL; Richardson BC
    J Clin Invest; 1993 Jul; 92(1):38-53. PubMed ID: 7686923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus function in drug-induced lupus.
    Rubin RL; Salomon DR; Guerrero RS
    Lupus; 2001; 10(11):795-801. PubMed ID: 11789489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs.
    Rubin RL
    Clin Biochem; 1992 Jun; 25(3):223-34. PubMed ID: 1633638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of autoreactive T cells that help nucleobindin-injected mice produce anti-DNA antibodies.
    Kubota T; Watanabe N; Kaneko T; Satake F; Miura K; Kurosawa Y; Miyasaka N; Kanai Y
    Immunol Lett; 2001 Jan; 75(2):111-5. PubMed ID: 11137134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice.
    Duncan SR; Rubin RL; Burlingame RW; Sinclair SB; Pekny KW; Theofilopoulos AN
    Clin Immunol Immunopathol; 1996 May; 79(2):171-81. PubMed ID: 8620623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.